Sanofi ( #sny ) has released " 6-K - Sanofi (0001121404) (Filer) " on Thu 13 Feb at 12:23 EST #tax #UnitedStates #ClinicalTrials #media #EPS
https://grafa.com/asset/sanofi-adr-15504-sny.nasdaq?utm_source=nasdaq_mkt_announcements&utm_medium=mastodon&utm_campaign=sny.nasdaq

Recce Pharmaceuticals ( #RCE ) has released " Trading Halt " on Thu 13 Feb at 11:56 AEST #trading #ClinicalTrials #media #ltd #ASX
https://grafa.com/asset/recce-ltd-9590-rce.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=rce.asx

Island Pharmaceuticals ( #ILA ) has released " Completion of patient dosing in Phase 2b clinical trial " on Wed 12 Feb at 09:33 AEST #ClinicalTrials #Australia #News #media #ltd
https://grafa.com/asset/island-pharmaceuticals-ltd-7742-ila.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=ila.asx

Memphasys ( #MEM ) has released " Felix Clinical Trial complete, Data Lock expected in 2 weeks " on Tue 11 Feb at 10:05 AEST #ClinicalTrials #India #Australia #media #Strategy
https://grafa.com/asset/memphasys-ltd-8352-mem.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=mem.asx

Clarity Pharmaceuticals ( #CU6 ) has released " Clarity expands pipeline with Cu-64/67 SAR-trastuzumab " on Tue 11 Feb at 09:40 AEST #UnitedStates #ClinicalTrials #Australia #News #media
https://grafa.com/asset/clarity-pharmaceuticals-ltd-6504-cu6.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cu6.asx